Skip to content
Home/Companies/Biotech/BioC3

BioC3

Biotech·France·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns BioC3?

BioC3 is currently owned by Irdi Capital-Investissement through IRDInov 3 (2023 vintage), since 2024.

Hand-verified · updated 2026-07-16

Irdi Capital-Investissement
Investor
Irdi Capital-Investissement
IRDInov 3 · 2023 · VC

Key facts

HQFrance
SectorBiotech
StatusActive

More from IRDInov 3

Other portfolio companies in the same fund.

DiappyMed
DiappyMed
Active
MedTechFrance· 2026
CORPO EVENTS
Corpo Events
Active
HospitalityFrance· 2025
Feedae
Active
SaaSFrance· 2025
PeopleSpheres
Active
HR TechFrance· 2025
SIM AND Cure
Active
MedTechFrance· 2025
APPVIZER
Appvizer
Active
SaaSFrance· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track BioC3

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy BioC3?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on BioC3.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue